These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 13072086)

  • 21. The hemagglutination reaction to BCG and vole bacillus vaccinations.
    HAWIRKO RZ
    Can J Microbiol; 1954 Aug; 1(1):79-84. PubMed ID: 14352042
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparison of vaccination with vole bacillus and B.C.G. vaccines.
    FREW HW; DAVIDSON JR; REID JT
    Br Med J; 1955 Jan; 1(4906):133-6. PubMed ID: 13219360
    [No Abstract]   [Full Text] [Related]  

  • 23. [Latent allergy disclosed by the full bacillary bodies and antituberculous resistance brought about by the BCG vaccination].
    BRETEY J; NEGRE L
    Bull Acad Natl Med; 1956 Apr 17-24; 140(13-14):224-5. PubMed ID: 13364454
    [No Abstract]   [Full Text] [Related]  

  • 24. EXPERIMENTAL studies of vaccination, allergy, and immunity in tuberculosis. VI. Comparative effects of BCG, H37Ra, Mycobacterium phlei and a wax-protein fraction of human tubercle bacilli.
    Am J Hyg; 1955 Nov; 62(3):270-82. PubMed ID: 13268417
    [No Abstract]   [Full Text] [Related]  

  • 25. Viability and multiplication of vaccines in immunization against tuberculosis.
    BLOCH H; SEGAL W
    Am Rev Tuberc; 1955 Feb; 71(2):228-48. PubMed ID: 14350182
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cellular-Koch bacillus interactions. Discovery of non-specific principles capable of augmenting cellular resistance].
    DELAUNAY A
    Vie Med; 1962 Feb; 43():261-8. PubMed ID: 13885077
    [No Abstract]   [Full Text] [Related]  

  • 27. Importance of administration of vaccine in active prevention of tuberculosis with BCG and with dead bacteria; Sivori's enzyme reaction to guinea pig following intradermal and hypodermal administration of BCG and of whole Petragnani anatuberculin.
    ESPOSTI AD
    Clin Pediatr (Bologna); 1953 Jan; 35(1):56-61. PubMed ID: 13042981
    [No Abstract]   [Full Text] [Related]  

  • 28. [TUBERCULOSIS VACCINATION WITH THE KILLED BCG].
    PHAMNGOC TACH ; D ANGDUC TRACH ; NGUYENTHIH OI
    Poumon Coeur; 1964; 20():923-48. PubMed ID: 14244375
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of the immunizing properties of BCG, ultraviolet irradiated vaccines, and various lipid antigens in rats, mice and guinea pigs.
    SMITH DW; GROVER AA; NUNGESTER WJ
    Med Bull (Ann Arbor); 1953 May; 19(5):122-9. PubMed ID: 13078097
    [No Abstract]   [Full Text] [Related]  

  • 30. [Contribution to the study of biological behaviors induced by antituberculosis vaccination with living and dead micro-organisms].
    DEGLI ESPOSTI A
    Lotta Tuberc; 1953; 23(1-2):78-89. PubMed ID: 13062671
    [No Abstract]   [Full Text] [Related]  

  • 31. B.C.G. and vole bacillus vaccines in the prevention of tuberculosis in adolescents.
    Br Med J; 1959 Sep; 2(5149):379-96. PubMed ID: 13856755
    [No Abstract]   [Full Text] [Related]  

  • 32. Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis.
    Aldwell FE; Cross ML; Fitzpatrick CE; Lambeth MR; de Lisle GW; Buddle BM
    Vaccine; 2006 Mar; 24(12):2071-8. PubMed ID: 16332403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. REGRESSION TECHNIQUES TO SOLVE UNEQUAL CHALLENGE POTENCY PROBLEMS IN ANTITUBERCULOSIS VACCINE ASSAYS.
    HOYT A; MOORE FJ; THOMPSON MA
    Am Rev Respir Dis; 1964 Jan; 89():111-5. PubMed ID: 14117678
    [No Abstract]   [Full Text] [Related]  

  • 34. Persistence of Mycobacterium bovis Bacillus Calmette-Guérin in white-tailed deer (Odocoileus virginianus) after oral or parenteral vaccination.
    Palmer MV; Thacker TC; Waters WR; Robbe-Austerman S; Lebepe-Mazur SM; Harris NB
    Zoonoses Public Health; 2010 Dec; 57(7-8):e206-12. PubMed ID: 20707863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [OUR METHOD OF PREVENTION BY VACCINE OF TUBERCULOUS INFECTION IN INFANTS. ITERATIVE ORAL IMPREGNATION AND CUTI-BCG(LIVE GERMS) SYSTEMATICALLY REPEATED].
    FOURESTIER M
    Rev Esp Tuberc; 1963 Sep; 32():463-70. PubMed ID: 14121738
    [No Abstract]   [Full Text] [Related]  

  • 36. IN VITRO STUDIES ON THE INTERACTIONS BETWEEN MACROPHAGES OF RABBITS AND TUBERCLE BACILLI. II. CELLULAR AND HUMORAL ASPECTS OF ACQUIRED RESISTANCE.
    HSU HS
    Am Rev Respir Dis; 1965 Apr; 91():499-509. PubMed ID: 14263929
    [No Abstract]   [Full Text] [Related]  

  • 37. Assessment of the first results of the Medical Research Council's trial of tuberculosis vaccines in adolescents in Great Britain.
    D'ARCY HART P; POLLOCK TM; SUTHERLAND I
    Bibl Tuberc; 1957; 13(12):171-89. PubMed ID: 13471494
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experimental research on the distribution of tubercle bacilli in the skeleton by means of radioactive BCG vaccine].
    CAPUTO V; STROM L; TESSAROLO G
    Arch Tisiol Mal Appar Respir; 1952 Apr; 7(4):310-8. PubMed ID: 13017926
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparison of different BCG vaccines by means of bovine and human tuberculosis bacilli labeled with C14 (14CH3CO2Na)].
    PASQUIER JF; KURYLOWICZ W
    Rev Immunol Ther Antimicrob; 1956; 20(3):139-60. PubMed ID: 13351062
    [No Abstract]   [Full Text] [Related]  

  • 40. Immune response profiles of calves following vaccination with live BCG and inactivated Mycobacterium bovis vaccine candidates.
    van der Heijden EMDL; Chileshe J; Vernooij JCM; Gortazar C; Juste RA; Sevilla I; Crafford JE; Rutten VPMG; Michel AL
    PLoS One; 2017; 12(11):e0188448. PubMed ID: 29155877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.